par Andriole, Gerald;Bostwick, David;Brawley, O.W.;Gomella, Leonard LG;Marberger, Michael Johann;Montorsi, Francesco;Pettaway, Curtis CA;Tammela, Teuvo TL;Teloken, Claudio;Tindall, Donald DJ;Somerville, Matthew;Wilson, Timothy H;Fowler, Ivy IL;Rittmaster, Roger;Van Velthoven, Roland 
; [et al.]
Référence The New England journal of medicine, 362, 13, page (1192-1202)
Publication Publié, 2010-04
; [et al.]Référence The New England journal of medicine, 362, 13, page (1192-1202)
Publication Publié, 2010-04
Article révisé par les pairs
| Titre: |
|
| Auteur: | Andriole, Gerald; Bostwick, David; Brawley, O.W.; Gomella, Leonard LG; Marberger, Michael Johann; Montorsi, Francesco; Pettaway, Curtis CA; Tammela, Teuvo TL; Teloken, Claudio; Tindall, Donald DJ; Somerville, Matthew; Wilson, Timothy H; Fowler, Ivy IL; Rittmaster, Roger; Van Velthoven, Roland; et al. |
| Informations sur la publication: | The New England journal of medicine, 362, 13, page (1192-1202) |
| Statut de publication: | Publié, 2010-04 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | 5-alpha Reductase Inhibitors |
| Aged | |
| Azasteroids -- adverse effects -- therapeutic use | |
| Biopsy | |
| Double-Blind Method | |
| Enzyme Inhibitors -- adverse effects -- therapeutic use | |
| Erectile Dysfunction -- chemically induced | |
| Heart Failure -- chemically induced | |
| Humans | |
| Male | |
| Middle Aged | |
| Prostate -- pathology | |
| Prostate-Specific Antigen -- blood | |
| Prostatic Hyperplasia -- drug therapy -- pathology | |
| Prostatic Neoplasms -- genetics -- pathology -- prevention & control | |
| Protein Isoforms | |
| Risk | |
| Treatment Outcome | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0028-4793 |
| info:doi/10.1056/NEJMoa0908127 | |
| info:pii/362/13/1192 | |
| info:pmid/20357281 |
